These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 8017724
21. Diagnosis and management of tuberculosis. Harris AA, Karakusis P. Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269 [No Abstract] [Full Text] [Related]
22. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM, Goldberg SV. Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [Abstract] [Full Text] [Related]
23. Description of primary multidrug-resistant tuberculous meningitis in an Italian child. Mauro MV, Cavalcanti P, Ledonne R, Giraldi C, Sperlì D. Microb Drug Resist; 2012 Feb; 18(1):71-3. PubMed ID: 21711151 [Abstract] [Full Text] [Related]
24. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia. Sar B, Keo C, Leng C, Saman M, Min DC, Chan S, Monchy D, Sarthou JL. Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041 [Abstract] [Full Text] [Related]
25. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial. Newman R, Doster BE, Murray FJ, Woolpert SF. Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541 [No Abstract] [Full Text] [Related]
26. Neuro-tuberculosis, An unsolved problem. Vejjajiva A. J Med Assoc Thai; 1974 Feb; 57(2):89-92. PubMed ID: 4212192 [No Abstract] [Full Text] [Related]
27. Advances in the treatment of tuberculosis. Clarke PD. J R Nav Med Serv; 1976 Feb; 62(2):85-91. PubMed ID: 61273 [No Abstract] [Full Text] [Related]
28. Multidrug-resistant tuberculosis and its control. Kochi A, Vareldzis B, Styblo K. Res Microbiol; 1993 Feb; 144(2):104-10. PubMed ID: 8337467 [No Abstract] [Full Text] [Related]
29. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Mitchison DA. Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106 [Abstract] [Full Text] [Related]
31. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia. Singla R, Al-Sharif N, Al-Sayegh MO, Osman MM, Shaikh MA. Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297 [Abstract] [Full Text] [Related]
32. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3. Oka S, Sasaki M, Kobayashi T, Matsuda T. Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627 [No Abstract] [Full Text] [Related]
36. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S. East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [Abstract] [Full Text] [Related]
37. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Vernon A, Burman W, Benator D, Khan A, Bozeman L. Lancet; 1999 May 29; 353(9167):1843-7. PubMed ID: 10359410 [Abstract] [Full Text] [Related]
38. Presumed ocular and central nervous system tuberculosis in a patient with the acquired immunodeficiency syndrome. Muccioli C, Belfort R. Am J Ophthalmol; 1996 Feb 29; 121(2):217-9. PubMed ID: 8623897 [Abstract] [Full Text] [Related]
39. The impact of chemotherapy on the care of patients with tuberculosis. Johnston RF, Wildrick KH. Am Rev Respir Dis; 1974 Jun 29; 109(6):636-64. PubMed ID: 4209115 [No Abstract] [Full Text] [Related]